🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Photobiomodulation in Chronic Fatigue Syndrome

RecruitingNAAges 18 Years - 60 YearsAllUniversity of Lahore
NCT07546539 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to evaluate whether photobiomodulation therapy (low-level laser therapy) can reduce fatigue and improve quality of life in patients with chronic fatigue syndrome (CFS). The study will include adults aged 18-60 years diagnosed with chronic fatigue syndrome. The main questions it aims to answer are: Does photobiomodulation therapy significantly reduce fatigue levels as measured by the Fatigue Severity Scale (FSS) and Multidimensional Fatigue Inventory (MFI-20)? Does photobiomodulation therapy improve pain, functional capacity, sleep quality, and psychological well-being in patients with chronic fatigue syndrome? Researchers will compare the low-level laser therapy group with a placebo (sham laser) group to determine whether photobiomodulation therapy leads to greater improvements in fatigue, pain, and overall quality of life. Participants will: Recei

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria * Age 18-60 years * Diagnosis of a CFS according to the 2015 Institute of Medicine criteria * Fatigue Severity Scale (FSS) score ≥ 4 * Ability to understand study procedures and provide informed consent Exclusion Criteria * Comorbid psychiatric conditions (e.g., major depression, schizophrenia) * Current use of corticosteroids or immunomodulators * Known photosensitivity or dermatologic contraindications to LLLT * Participation in structured exercise programs more than twice weekly * Diagnosed malignancy or active infection -Not willing to be the part of study -
💊

What it tests

  • Photobiomodulation (Low-Level Laser Therapy)
  • sham Photobiomodulation (LLLT)
📍

Where

1 site
The larkana General hospital , larkana
Larkana, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy